New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').
Fabrizio Schifano, Paolo Deluca, Lisa Agosti, Giovanni Martinotti, John Corkery
Journal of Psychopharmacology November 1, 2005 DOI: 10.1177/0269881105056660 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Sample size | 118 |
| Population | Websites discussing 2C-T-7 |
| Keywords | Online drug trends Digital drug trends Internet drug trends Cyber drug trends Drug monitoring Drug surveillance Designer drugs Novel psychoactive substances Research chemicals Synthetic drugs Drug prevention Substance abuse prevention Harm reduction Drug education Public health Online drug markets Internet drug sales Cyber drug markets Digital drug trade Illicit online trade |
| Citations | 70 |
| Key findings | Online information about 2C-T-7 is extensive, but street-level availability in Europe is very low, with only one documented US death from mono-intoxication. |
Abstract
2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-intoxication with 2C-T-7 has been documented in the USA. With respect to information on 2C-T-7 available online, due to both redundancy and relevance issues the initial identified sample of 360 was reduced to 118 websites. In 14 (11.9%) websites, the detailed description of the 2C-T-7 synthesis was given. Harm Reduction websites appeared significantly earlier in the search engines results' list than Anti drugs (p 0.006) websites. Five (4.2%) websites apparently offered 2C-T-7 for sale. The large body of knowledge available online seems to contrast with small numbers of seizures at street level; an exhaustive web mapping of drug-related issues may be of interest for the clinician. Projects aimed at designing more 'attractive' prevention websites should be planned and future studies should better assess the characteristics of those consumers who take advantage of the online information of hallucinogenic compounds.
Citations in the library
Cited by 15
- Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives Brain Sciences March 16, 2018
- Substance-related exogenous psychosis: a postmodern syndrome CNS Spectrums June 25, 2020
- Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset CNS & Neurological Disorders - Drug Targets April 17, 2017
- Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series). Biochemical Pharmacology January 15, 2007
- Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics February 1, 2008
and 10 more in the library
Cites 10
- Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Journal of Pharmacology and Experimental Therapeutics September 1, 1988
- Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research Pharmacopsychiatry July 1, 1998
- A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharmacy world & science : PWS April 1, 2004
- Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148 Archives of General Psychiatry September 1, 1959
- Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD) Neuropsychopharmacology August 1, 1999
and 5 more in the library